The blood-brain barrier: Regulatory roles in wakefulness and sleep

Neuroscientist

Volumn 23, Issue 2, 2017, Pages 124-136

  Pan, Weihong ^a   Kastin, Abba J ^b  

^a Biopotentials Sleep Center   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Blood brain barrier; Chronobiology; Circadian rhythm; CNS drug; Glucose; Obesity; Permeability; Pgp; Sleep; Solute carrier; Synaptic function; Tight junction; Transport

Indexed keywords

GLUCOSE; MULTIDRUG RESISTANCE PROTEIN; SOLUTE CARRIER PROTEIN;

AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CHRONOBIOLOGY; CIRCADIAN RHYTHM; HUMAN; MEMBRANE PERMEABILITY; NERVE DEGENERATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SLEEP; SLEEP DEPRIVATION; SYNAPSE; TIGHT JUNCTION; WAKEFULNESS; ANIMAL; DEGENERATIVE DISEASE; METABOLISM; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CIRCADIAN RHYTHM; HUMANS; NEURODEGENERATIVE DISEASES; SLEEP; SLEEP DEPRIVATION; WAKEFULNESS;

EID: 85018665757     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858416639005     Document Type: Review

References (122)

1. Abbott NJ 2005. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25: 5-23.
2. Abbott NJ 2008. Cellular composition of the blood-brain barrier (BBB). Henry Stewart Talks. https://hstalks.com/t/757/cellular-composition-of-the-blood-brain-barrier/.
3. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. 2010. Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25.
4. Agorastos A, Hauger RL, Barkauskas DA, Moeller-Bertram T, Clopton PL, Haji U, and others. 2014. Circadian rhythmicity, variability and correlation of interleukin-6 levels in plasma and cerebrospinal fluid of healthy men. Psychoneuroendocrinology 44: 71-82.
5. Anthony D, Dempster R, Fearn S, Clements J, Wells G, Perry VH, and others. 1998. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol 8: 923-6.
6. Baker DG, Bertram TM, Patel PM, Barkauskas DA, Clopton P, Patel S, and others. 2013. Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe. Psychoneuroendocrinology 38: 2378-82.
7. Banks WA 2015. Peptides and the blood-brain barrier. Peptides 72: 16-9.
8. Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, and others. 2015. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation 12: 223.
9. Banks WA, Kastin AJ, Ehrensing CA. 1998. Diurnal uptake of circulating interleukin-1α by brain, spinal cord, testis and muscle. Neuroimmunomodulation 5: 36-41.
10. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305-11.
11. Banks WA, Kastin AJ, Maness LM, Banks MF, Shayo M, McLay RN. 1997. Interactions of β-amyloids with the blood-brain barrier. Ann N Y Acad Sci 826: 190-9.
12. Banks WA, Kastin AJ, Selznick JK. 1985. Modulation of immunoactive levels of DSIP and blood-brain barrier permeability by lighting and diurnal rhythm. J Neurosci Res 14: 347-55.
13. Blazquez JL, Rodriguez EM. 2010. The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid. Peptides 31: 757-76.
14. Boado RJ, Li JY, Tsukamoto H, Pardridge WM. 2003. Hypoxia induces de-stabilization of the LAT1 large neutral amino acid transporter mRNA in brain capillary endothelial cells. J Neurochem 85: 1037-42.
15. Borbely AA 1982. A two process model of sleep regulation. Hum Neurobiol 1: 195-204.
16. Chastrette N, Cespuglio R. 1985a. Influence of proopiomelanocortin-derived peptides on the sleep-waking cycle of the rat. Neurosci Lett 62: 365-70.
17. Chastrette N, Cespuglio R. 1985b. Hypnogenic effects of desacetyl-α-MSH and CLIP (ACTH 18-39) in the rat). C R Acad Sci III [in French] 301: 527-30.
18. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, and others. 2005. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115: 3285-90.
19. Cohen-Kashi-Malina K, Cooper I, Teichberg VI. 2012. Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells. J Cereb Blood Flow Metab 32: 177-89.
20. Cucullo L, Couraud PO, Weksler B, Romero IA, Hossain M, Rapp E, and others. 2008. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab 28: 312-28.
21. De Vries HE, Kuiper J, De Boer AG, van Berkel TJ, Breimer DD. 1997. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 49: 143-55.
22. Dodelet-Devillers A, Cayrol R, van Horssen J, Haqqani AS, De Vries HE, Engelhardt B, and others. 2009. Functions of lipid raft membrane microdomains at the blood-brain barrier. J Mol Med 87: 765-74.
23. Engelhardt B. 2008. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J Neurol Sci 274: 23-6.
24. Fernstrom JD 2013. Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino Acids 45: 419-30.
25. Gan EH, Quinton R. 2010. Physiological significance of the rhythmic secretion of hypothalamic and pituitary hormones. Prog Brain Res 181: 111-26.
26. Gottesmann C. 2002. GABA mechanisms and sleep. Neuroscience 111: 231-9.
27. Graf MV, Kastin AJ. 1984. Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev 8: 83-93.
28. Graf MV, Kastin AJ. 1986. Delta-sleep-inducing peptide (DSIP): an update. Peptides 7: 1165-87.
29. Grima N, Ponsford J, Rajaratnam S, Mansfield D, Pase MP. 2015. Sleep disturbances in traumatic brain injury: a meta-analysis. J Clin Sleep Med Nov 26 [Epub ahead of print].
30. Guan Z, Vgontzas AN, Bixler EO, Fang J. 2008. Sleep is increased by weight gain and decreased by weight loss in mice. Sleep 31: 627-33.
31. Halassa MM, Fellin T, Haydon PG. 2009. Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57: 343-6.
32. Harrington ME 2012. Neurobiological studies of fatigue. Prog Neurobiol 99: 93-105.
33. He C, Yang Y, Zhang M, Price JL, Zhao Z. 2013. Regulation of sleep by neuropeptide Y-like system in Drosophila melanogaster. PLoS One 8: e74237.
34. He J, Hsuchou H, He Y, Kastin AJ, Mishra PK, Fang J, and others. 2014a. Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis. Fluids Barriers CNS 11: 27.
35. He J, Hsuchou H, He Y, Kastin AJ, Wang Y, Pan W. 2014b. Sleep restriction impairs blood-brain barrier function. J Neurosci 34: 14697-706.
36. He J, Kastin AJ, Wang Y, Pan W. 2015. Sleep fragmentation has differential effects on obese and lean mice. J Mol Neurosci 55: 644-52.
37. He J, Wang Y, Kastin AJ, Pan W. 2014c. Increased sleep fragmentation in experimental autoimmune encephalomyelitis. Brain Behav Immun 38: 53-8.
38. He Y, Cornelissen-Guillaume GG, He J, Kastin AJ, Harrison LM, Pan W. 2016. Circadian rhythm of autophagy proteins in hippocampus is blunted by sleep fragmentation. Chronobiol Int. in press
39. Herring WJ, Snyder E, Budd K, Hutzelmann J, Snavely D, Liu K, and others. 2012. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 79: 2265-74.
40. Hsuchou H, Wang Y, Cornelissen-Guillaume GG, Kastin AJ, Jang E, Halberg F, and others. 2013. Diminished leptin signaling can alter circadian rhythm of metabolic activity and feeding. J Appl Physiol 115: 995-1003.
41. Huang Q, Liao J, Liu Y, Liang H, Ma P, Pan J. 2015. Plasma neuropeptide Y levels in Chinese patients with primary insomnia. Sleep Breath 19: 617-22.
42. Isakovic AJ, Abbott NJ, Redzic ZB. 2004. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat. J Neurochem 90: 272-86.
43. Jenkins JB, Omori T, Guan Z, Vgontzas AN, Bixler EO, Fang J. 2006. Sleep is increased in mice with obesity induced by high-fat food. Physiol Behav 87: 255-62.
44. Kakee A, Takanaga H, Terasaki T, Naito M, Tsuruo T, Sugiyama Y. 2001. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier. J Neurochem 79: 110-8.
45. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, and others. 2009. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science 326: 1005-7.
46. Kastin AJ, Akerstrom V. 1999a. Entry of CART into brain is rapid but not inhibited by excess CART or leptin. Am J Physiol 277: E901-4.
47. Kastin AJ, Akerstrom V. 1999b. Nonsaturable entry of neuropeptide Y into brain. Am J Physiol 276: E479-82.
48. Kastin AJ, Akerstrom V. 1999c. Orexin A but not Orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 289: 219-23.
49. Kastin AJ, Akerstrom V. 2002. Differential interactions of urocortin/corticotropin-releasing hormone peptides with the blood-brain barrier. Neuroendocrinology 75: 367-74.
50. Kastin AJ, Akerstrom V, Hackler L, Zadina JE. 2000. Phe(13),Tyr(19)-melanin-concentration hormone and the blood-brain barrier: role of protein binding. J Neurochem 74: 385-91.
51. Kastin AJ, Fabre LA. 1982. Limitations to effect of α-MSH on permeability of blood-brain barrier to IV 99mTc-pertechnetate. Pharmacol Biochem Behav 17: 1199-201.
52. Kastin AJ, Hahn K, Zadina JE. 2001. Regional differences in peptide degradation by rat cerebral microvessels: a potential novel regulatory mechanism for communication between blood and brain. Life Sci 69: 1305-12.
53. Kastin AJ, Nissen C, Coy DH. 1981. Permeability of blood-brain barrier to DSIP peptides. Pharmacol Biochem Behav 15: 955-9.
54. Kastin AJ, Pan W. 2003. Feeding peptides interact in several ways with the blood-brain barrier. Curr Pharm Des 9: 789-94.
55. Kastin AJ, Pan W. 2008. Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides. Curr Pharm Des 14: 1615-19.
56. Kastin AJ, Pan W, Maness LM, Banks WA. 1999. Peptides crossing the blood-brain barrier: some unusual observations. Brain Res 848: 96-100.
57. Keating GL, Kuhar MJ, Bliwise DL, Rye DB. 2010. Wake promoting effects of cocaine and amphetamine-regulated transcript (CART). Neuropeptides 44: 241-6.
58. Kim DG, Bynoe MS. 2015. A2A adenosine receptor regulates the human blood-brain barrier permeability. Mol Neurobiol 52: 664-78.
59. Kim HJ, Harrington ME. 2008. Neuropeptide Y-deficient mice show altered circadian response to simulated natural photo-period. Brain Res 1246: 96-100.
60. Knowland D, Arac A, Sekiguchi KJ, Hsu M, Lutz SE, Perrino J, and others. 2014. Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 82: 603-17.
61. Krieger DT, Allen W, Rizzo F, Krieger HP. 1971. Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab 32: 266-84.
62. Krueger JM 2008. The role of cytokines in sleep regulation. Curr Pharm Des 14: 3408-16.
63. Laposky AD, Bradley MA, Williams DL, Bass J, Turek FW. 2008. Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 295: R2059-66.
64. Laposky AD, Shelton J, Bass J, Dugovic C, Perrino N, Turek FW. 2006. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 290: R894-903.
65. Lécuyer MA, Kebir H, Prat A. 2016. Glial influences on BBB functions and molecular players in immune cell trafficking. Biochim Biophys Acta 1862: 472-82.
66. + nucleoside transporter CNT2 cloned from rat blood-brain barrier. J Pharmacol Exp Ther 299: 735-40.
67. Martins JM, Banks WA, Kastin AJ. 1997. Acute modulation of active carrier-mediated brain-to-blood transport of corticotropin-releasing hormone. Am J Physiol 272: E312-9.
68. Martins JM, Kastin AJ, Banks WA. 1996. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology 63: 338-48.
69. McCall AL, Millington WR, Wurtman RJ. 1982. Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport. Life Sci 31: 2709-15.
70. Monti JM, Lagos P, Jantos H, Torterolo P. 2015. Increased REM sleep after intra-locus coeruleus nucleus microinjection of melanin-concentrating hormone (MCH) in the rat. Prog Neuropsychopharmacol Biol Psychiatry 56: 185-8.
71. Monti JM, Torterolo P, Lagos P. 2013. Melanin-concentrating hormone control of sleep-wake behavior. Sleep Med Rev 17: 293-8.
72. Nag S, Begley DJ. 2005. Blood-brain barrier, exchange of metabolites and gases. In: Kalimo H, editor. Pathology and genetics. Cerebrovascular diseases. Basel, Switzerland: ISN Neuropath Press. pp 2-29.
73. Nyberg F. 2000. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol 21: 330-48.
74. Opp MR, Obal F., Jr, Krueger JM. 1988. Effects of α-MSH on sleep, behavior, and brain temperature: interactions with IL 1. Am J Physiol 255: R914-22.
75. Pan W. 2015. From blood to brain through BBB and astrocytic signaling. Peptides 72: 127.
76. Pan W, Akerstrom V, Zhang J, Pejovic V, Kastin AJ. 2004. Modulation of feeding-related peptide/protein signals by the blood-brain barrier. J Neurochem 90: 455-61.
77. Pan W, Banks WA, Kennedy MK, Gutierrez EG, Kastin AJ. 1996. Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am J Physiol 271: E636-42.
78. Pan W, Cornelissen G, Halberg F, Kastin AJ. 2002a. Selected contribution: circadian rhythm of tumor necrosis factor-α uptake into mouse spinal cord. J Appl Physiol 92: 1357-62.
79. Pan W, Kastin AJ. 2001. Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system. Life Sci 68: 2705-14.
80. Pan W, Kastin AJ. 2003. Transport of cytokines and neurotrophins across the BBB and their regulation after spinal cord injury. In: Shanker H, Westman J, editors. Blood-spinal cord and brain barriers in health and disease. San Diego, CA: Academic Press. pp 395-407.
81. Pan W, Kastin AJ. 2007. Adipokines and the blood-brain barrier. Peptides 28: 1317-30.
82. Pan W, Kastin AJ. 2008a. Cytokine transport across the injured blood-spinal cord barrier. Curr Pharm Des 14: 1620-4.
83. Pan W, Kastin AJ. 2008b. Urocortin and the brain. Prog Neurobiol 84: 148-56.
84. Pan W, Kastin AJ. 2014. Can sleep apnea cause Alzheimer's disease? Neurosci Biobehav Rev 47: 656-69.
85. Pan W, Kastin AJ, Bell RL, Olson RD. 1999. Upregulation of tumor necrosis factor a transport across the blood-brain barrier after acute compressive spinal cord injury. J Neurosci 19: 3649-55.
86. Pan W, Solomon B, Maness LM, Kastin AJ. 2002b. Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide. Exp Biol Med (Maywood) 227: 609-15.
87. Pan W, Stone KP, Hsuchou H, Manda VK, Zhang Y, Kastin AJ. 2011. Cytokine signaling modulates blood-brain barrier function. Curr Pharm Des 17: 3729-40.
88. Pan W, Yu Y, Cain CM, Nyberg F, Couraud P-O, Kastin AJ. 2005. Permeation of growth hormone across the blood-brain barrier. Endocrinology 146: 4898-904.
89. Pan W, Yu Y, Nyberg F, Kastin AJ. 2006. Growth hormone, insulin, and insulin-like growth factor-I: do they interact at the blood-brain barrier? In: Nyberg F, editor. The somatotrophic axis in brain function. San Diego, CA: Academic Press. pp 75-79.
90. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ. 1997. Tumor necrosis factor-α: a neuromodulator in the CNS. Neurosci Biobehav Rev 21: 603-13.
91. Panskepp J, Reilly P, Bishop P, Meeker RB, Vilberg TR, Kastin AJ. 1976. Effects of α-MSH on motivation, vigilance and brain respiration. Pharmacol Biochem Behav 5: 59-64.
92. Pardridge WM, Mietus LJ. 1979. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest 64: 145-54.
93. Pardridge WM, Yoshikawa T, Kang YS, Miller LP. 1994. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J Pharmacol Exp Ther 268: 14-8.
94. Pelligrino DA, Vetri F, Xu HL. 2011. Purinergic mechanisms in gliovascular coupling. Semin Cell Dev Biol 22: 229-36.
95. Persidsky Y, Hill J, Zhang M, Dykstra H, Winfield M, Reichenbach NL, and others. 2015. Dysfunction of brain pericytes in chronic neuroinflammation. J Cereb Blood Flow Metab Sep 30 [Epub ahead of print]. doi: 10.1177/0271678X15606149.
96. Peruzzo B, Pastor FE, Blazquez JL, Schobitz K, Pelaez B, Amat P, and others. 2000. A second look at the barriers of the medial basal hypothalamus. Exp Brain Res 132: 10-26.
97. Petit JM, Tobler I, Kopp C, Morgenthaler F, Borbely AA, Magistretti PJ. 2010. Metabolic response of the cerebral cortex following gentle sleep deprivation and modafinil administration. Sleep 33: 901-8.
98. Poduslo JF, Curran GL, Sanyal B, Selkoe DJ. 1999. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier. Neurobiol Dis 6: 190-9.
99. Raeissi S, Audus KL. 1989. In vitro characterization of blood-brain barrier permeability to delta sleep-inducing peptide. J Pharm Pharmacol 41: 848-52.
100. Ramanathan A, Nelson AR, Sagare AP, Zlokovic BV. 2015. Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1. Front Aging Neurosci 7: 136.
101. Ribatti D, Nico B, Crivellato E, Artico M. 2006. Development of the blood-brain barrier: a historical point of view. Anat Rec B New Anat 289: 3-8.
102. Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, et al. 2012. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 4: 150ra122.
103. Ruderisch N, Virgintino D, Makrides V, Verrey F. 2011. Differential axial localization along the mouse brain vascular tree of luminal sodium-dependent glutamine transporters Snat1 and Snat3. J Cereb Blood Flow Metab 31: 1637-47.
104. Sankar R, Domer FR, Kastin AJ. 1981. Selective effects of α-MSH and MIF-1 on the blood-brain barrier. Peptides 2: 345-7.
105. Sensi S, Pace Palitti V, Guagnano MT. 1993. Chronobiology in endocrinology. Ann Ist Super Sanita 29: 613-31.
106. Szafarczyk A, Hery M, Laplante E, Ixart G, Assenmacher I, Kordon C. 1980. Temporal relationships between the cir-cadian rhythmicity in plasma levels of pituitary hormones and in hypothalamic concentrations of releasing factors. Neuroendocrinology 30: 369-76.
107. Takahashi Y, Kipnis DM, Daughaday WH. 1968. Growth hormone secretion during sleep. J Clin Invest 47: 2079-90.
108. Takanaga H, Ohtsuki S, Hosoya K, Terasaki T. 2001. GAT2/BGT-1 as a system responsible for the transport of γ-aminobutyric acid at the mouse blood-brain barrier. J Cereb Blood Flow Metab 21: 1232-9.
109. Tsacopoulos M, Magistretti PJ. 1996. Metabolic coupling between glia and neurons. J Neurosci 16: 877-85.
110. Tsujino N, Sakurai T. 2013. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci 7: 28.
111. Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J, and others. 2011. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117: 333-45.
112. Van CE 1990. Diurnal and ultradian rhythms in human endocrine function: a minireview. Horm Res 34: 45-53.
113. Wang Y, He J, Kastin AJ, Hsuchou H, Pan W. 2013. Hypersomnolence and reduced activity in pan-leptin receptor knockout mice. J Mol Neurosci 51: 1038-45.
114. Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. 1971. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 33: 14-22.
115. Wilson JF 1988. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive α-melanotropin. Psychopharmacology (Berl) 96: 262-6.
116. Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, and others. 2015. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18: 521-30.
117. Wolak DJ, Thorne RG. 2013. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm 10: 1492-504.
118. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, and others. 2013. Sleep drives metabolite clearance from the adult brain. Science 342: 373-7.
119. Yehuda S, Carasso RL. 1988. DSIP - a tool for investigating the sleep onset mechanism: a review. Int J Neurosci 38: 345-53.
120. Zhang Y, Liu GQ. 1998. Sodium and chloride-dependent high and low-affinity uptakes of GABA by brain capillary endothelial cells. Brain Res 808: 1-7.
121. 3H]inulin after osmotic opening in the rat. Exp Neurol 79: 845-57.
122. Zlokovic BV, Susic VT, Davson H, Begley DJ, Jankov RM, Mitrovic DM, and others. 1989. Saturable mechanism for delta sleep-inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea pig brain. Peptides 10: 249-54.